Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy Use in Patients With Lung Cancer and Comorbidities.
von Itzstein MS, Gonugunta AS, Mayo HG, Minna JD, Gerber DE. von Itzstein MS, et al. Among authors: gonugunta as. Cancer J. 2020 Nov/Dec;26(6):525-536. doi: 10.1097/PPO.0000000000000484. Cancer J. 2020. PMID: 33298724 Free PMC article. Review.
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.
von Itzstein MS, Gonugunta AS, Sheffield T, Homsi J, Dowell JE, Koh AY, Raj P, Fattah F, Wang Y, Basava VS, Khan S, Park JY, Popat V, Saltarski JM, Gloria-McCutchen Y, Hsiehchen D, Ostmeyer J, Xie Y, Li QZ, Wakeland EK, Gerber DE. von Itzstein MS, et al. Among authors: gonugunta as. Cancers (Basel). 2022 Mar 4;14(5):1327. doi: 10.3390/cancers14051327. Cancers (Basel). 2022. PMID: 35267634 Free PMC article.
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
von Itzstein MS, Gonugunta AS, Wang Y, Sheffield T, Lu R, Ali S, Fattah FJ, Xie D, Cai J, Xie Y, Gerber DE. von Itzstein MS, et al. Among authors: gonugunta as. Cancer Immunol Immunother. 2022 Sep;71(9):2183-2184. doi: 10.1007/s00262-022-03218-0. Cancer Immunol Immunother. 2022. PMID: 35596002 Free PMC article. No abstract available.
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors.
Mundra V, Yang Y, von Itzstein MS, Fattah F, Gonugunta AS, Hannan R, Pop LM, Zhang Y, Wang Y, Sheffield T, Xie Y, Dowell JE, Homsi J, Rashdan S, Park J, Li QZ, Wakeland EK, Gerber DE. Mundra V, et al. Among authors: gonugunta as. Transl Oncol. 2023 Aug;34:101689. doi: 10.1016/j.tranon.2023.101689. Epub 2023 Jun 6. Transl Oncol. 2023. PMID: 37285748 Free PMC article.
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
von Itzstein MS, Gonugunta AS, Wang Y, Sheffield T, Lu R, Ali S, Fattah FJ, Xie D, Cai J, Xie Y, Gerber DE. von Itzstein MS, et al. Among authors: gonugunta as. Cancer Immunol Immunother. 2022 Sep;71(9):2169-2181. doi: 10.1007/s00262-022-03151-2. Epub 2022 Jan 24. Cancer Immunol Immunother. 2022. PMID: 35072744 Free PMC article.